Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled PGE1 in Neonates with Sub-Optimal Response to iNO
NCT01467076Phase 2Terminated
- Sponsor
- NICHD Neonatal Research Network
- Start
- Nov 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Vasostenoon in hypoxemic respiratory failure, sponsored by NICHD Neonatal Research Network. Started Nov 2011; status: terminated.
02
Drugs
Vasostenoon
03
Conditions
hypoxemic respiratory failure
Beyond the preview
Go deeper on NCT01467076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01467076.